Wörwag Pharma GmbH & Co. KG is a pharmaceutical company with subsidiaries worldwide. The company develops and sells biofactor preparations. Biofactors are e. g. vitamins, minerals, and trace elements.
The range of products of Wörwag Pharma comprises both prescription preparations and over the counter (OTC) products and food supplements. Most of the products, which are sold exclusively in pharmacies, are used to treat diabetic comorbidities such as neuropathy (nerve damage) as well as cardiovascular and neurological diseases.
In 2019, the company with a staff of 1,000 employees in more than 35 countries achieved sales of 234 million euros.
Wörwag Pharma is a family-owned company led by Gerhard Mayer, and Jochen Schlindwein.
Dr. Fritz Wörwag founded the company in Stuttgart in 1971. Its headquarters are in Böblingen.